Search results
KFF Analysis Finds an Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be...
Sierra Sun Times· 4 days agoIn a new analysis, KFF finds that 3.6 million people with Medicare could be eligible for coverage of...
3.6 million Medicare recipients could qualify for Wegovy under new rule
UPI· 5 days agoThe U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the...
1 in 4 Medicare beneficiaries with obesity could get Wegovy despite coverage ban
The Hill· 5 days agoAn estimated 3.6 million Medicare beneficiaries could potentially access Wegovy since the Food and...
Senate to probe Ozempic, Wegovy's cost
Becker’s Hospital Review· 6 days agoIn an April 24 letter to Novo Nordisk's CEO, the Senate Committee on Health, Education, Labor, and Pensions said Ozempic and Wegovy are "exorbitantly expensive," which restricts access to the ...
How one state is trying to make weight loss drugs cheaper
NBC Universal via AOL· 5 days agoWeight loss drugs aren't covered by insurance for North Carolina's state employees. The state is...
Sanders launches Senate investigation into ‘outrageously high’ pricing of Ozempic, Wegovy | CNN
CNN.com· 4 days agoSen. Bernie Sanders is taking aim at the high prices of the blockbuster drugs Ozempic and Wegovy....
New Rules Mean 3.6 Million Americans Could Get Wegovy Via Medicare, Costing Billions
US News & World Report· 5 days agoA budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says. The FDA’s ruling potentially allows Wegovy prescription ...
Dr. Loh: How do you know a new treatment is better?
VC Star | Ventura County Star via Yahoo News· 2 days agoWe also have novel GLP-1 therapies more potent than semaglutide (Ozempic) that we are evaluating to not only affect weight, but reduce the odds of having...
Why GLP-1 Drugs May Improve Sleep Apnea
Verywell Health via Yahoo News· 4 days agoEli Lilly reported its phase 3 clinical trial data that showed showed significant reduction in sleep apnea symptoms in people who take Zepbound or...
Bernie Sanders slams pharma giant for ‘outrageously high’ drug prices, threatening the ‘entire...
Moneywise via Yahoo Finance· 2 days agoRead more: Jeff Bezos and Oprah Winfrey invest in this asset to keep their wealth safe...In 2023,...
